首頁 > 市場調查報告書 > 製藥

生物製劑基因治療學和RNAi 以基因為基之藥物開發

市場調查報告書

商品編碼

1510409

細胞凋亡檢測市場規模、佔有率和成長分析：按產品類型、檢測技術、應用、最終用戶、地區 - 產業預測，2024-2031

Apoptosis Assay Market Size, Share, Growth Analysis, By Product Type(Instruments, Assay Kits ), By Detection Technology, By Application, By End-User, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月03日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年細胞凋亡檢測市場規模預估為53.4億美元，預測期間（2024-2031年）複合年成長率為10.5%，從2023年的59億美元增加至2031年的131.2億美元，預計還會成長。

細胞凋亡檢測透過促進細胞凋亡機制的研究並評估其對疾病進展和治療的影響，在生物醫學研究、藥物發現和臨床診斷中發揮重要作用。這些檢測和測量與細胞凋亡相關的各種生化和細胞事件，包括 DNA 斷裂、絲胺酸外化、半胱天冬酶活化、粒線體膜電位變化和細胞色素 c 釋放。由於多種因素，全球細胞凋亡檢測市場近年來顯著成長。首先，癌症、神經退化性疾病和心血管疾病等慢性疾病的盛行率不斷增加，擴大使用細胞凋亡檢測來探討其潛在機制。此外，向個人化醫療和標靶治療的轉變增加了對準確有效的細胞凋亡檢測的需求，以評估藥物療效並指導治療決策。技術進步也發揮著重要作用，創新的檢測平台提高了靈敏度、特異性和通量。例如，流式細胞技術、螢光顯微鏡和高內涵篩檢系統等技術允許在單細胞層級同時分析多個細胞凋亡參數，從而徹底改變了細胞凋亡研究。總之，全球細胞凋亡檢測市場對於增進我們對程序性細胞死亡及其對疾病病理和治療策略的影響的理解至關重要。隨著持續的研究、技術創新和個人化醫療方法的不斷採用，市場有望持續成長，並為全球研究人員、臨床醫生和製藥公司提供必要的工具和見解。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Promega Corporation（United States）
Thermo Fisher Scientific Inc.（United States）
Bio-Rad Laboratories, Inc.（United States）
Merck KGaA（Germany）
PerkinElmer, Inc.（United States）
Abcam plc（United Kingdom）
Cell Signaling Technology, Inc.（United States）
BD Biosciences（United States）
GenScript Biotech Corporation（China）
Bio-Techne Corporation（United States）
Sartorius AG（Germany）
Beckman Coulter, Inc.（United States）
Enzo Biochem, Inc.（United States）
Lonza Group Ltd.（Switzerland）
Biotium, Inc.（United States）
Trevigen, Inc.（United States）
Essen Bioscience（United States）
Cayman Chemical Company（United States）
Abnova Corporation（Taiwan）
NanoString Technologies, Inc.（United States）

簡介目錄

Product Code: SQMIG35I2299

Apoptosis Assays Market size was valued at USD 5.34 billion in 2022 and is poised to grow from USD 5.90 billion in 2023 to USD 13.12 billion by 2031, at a CAGR of 10.5% during the forecast period (2024-2031).

Apoptosis assays play a crucial role in biomedical research, drug discovery, and clinical diagnostics by facilitating the study of apoptosis mechanisms and assessing their impact on disease progression and treatments. These assays enable the detection and measurement of various biochemical and cellular events associated with apoptosis, such as DNA fragmentation, phosphatidylserine externalization, caspase activation, changes in mitochondrial membrane potential, and release of cytochrome c. They provide researchers and clinicians with valuable insights into cell death pathways, helping to evaluate therapeutic agents and identify potential drug targets. The global market for apoptosis assays has seen substantial growth recently driven by several factors. Firstly, there is a growing prevalence of chronic diseases like cancer, neurodegenerative disorders, and cardiovascular diseases, prompting increased use of apoptosis assays to explore their underlying mechanisms. Additionally, the shift towards personalized medicine and targeted therapies has heightened the demand for accurate and efficient apoptosis assays to assess drug efficacy and guide treatment decisions. Technological advancements have also played a pivotal role, with innovative assay platforms offering enhanced sensitivity, specificity, and throughput. For instance, technologies such as flow cytometry, fluorescence microscopy, and high-content screening systems have revolutionized apoptosis research by enabling simultaneous analysis of multiple apoptotic parameters at the single-cell level. In conclusion, the global apoptosis assays market is pivotal in advancing our understanding of programmed cell death and its implications in disease pathology and therapeutic strategies. With ongoing research, technological innovations, and increasing adoption of personalized medicine approaches, the market is poised for continued growth, providing indispensable tools and insights to researchers, clinicians, and pharmaceutical companies worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Apoptosis Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Apoptosis Assays Market Segmental Analysis

The global apoptosis assays market is segmented based on product type, detection technology, application, end-user, and region. By product, the market is segmented into Instruments, Assay Kits (Caspase Assays, Annexin V and Cell Permeability Assays, DNA Fragmentation Assays, Mitochondrial Assays), Reagents, Microplates. Based on Detection Technology, the market is segmented into Flow Cytometry, Cell Imaging and Microscopy, Spectrophotometry, and Others. By Application, the market is segmented into Drug Discovery and Development, Clinical and Diagnostic Applications, Basic Research, Stem Cell Research. By end-user, the market is segmented into pharmaceutical & biotechnology companies, hospital & diagnostic laboratories, and academic & research institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

Drivers of the Apoptosis Assays Market

The global market is expected to see substantial growth due to significant investments by industry players in developing advanced and cost-effective assay kits, alongside increasing demand from users for apoptosis assay kits. Reagents play a critical role in apoptosis testing methods, prompting numerous kit manufacturers to introduce a variety of products incorporating innovative reagents that improve the detection and monitoring of cell death. This trend is expected to drive growth in the apoptosis assays market in the forecasted period.

Restraints in the Apoptosis Assays Market

There is a shortage of skilled personnel for apoptosis assay research and development. Cells can undergo apoptosis or necrosis, with necrosis typically involving cell swelling and rupture following acute injury, which can hinder the market's growth rate.

Market Trends of the Apoptosis Assays Market

There is a growing emphasis on personalized medicine within the healthcare sector, driving the demand for precise apoptosis assays. These assays are essential for assessing drug effectiveness, pinpointing therapy targets, and making treatment choices tailored to individual patient profiles. Concurrently, partnerships and collaborations between major industry stakeholders, academic institutions, and research bodies are increasingly prevalent. These alliances pool expertise and resources to accelerate technological advancements in apoptosis assays, foster innovation, and broaden market reach.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Patent Analysis
Value Chain Analysis
Ecosystem of the Market
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Apoptosis assays Market by Product Type

Market Overview
Assay Kits
- Caspase Assays
- Annexin V and Cell Permeability Assays
- DNA Fragmentation Assays
- Mitochondrial Assays
Instruments
Reagents
Microplates

Apoptosis assays Market by Detection Technology

Market Overview
Flow Cytometry
Cell Imaging and Microscopy
Spectrophotometry
Others

Apoptosis assays Market by Application

Market Overview
Drug Discovery and Development
Clinical and Diagnostic Applications
Basic Research
Stem Cell Research

Apoptosis assays Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Hospital & Diagnostic Laboratories
Academic & Research Institutes

Apoptosis assays Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Promega Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD Biosciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotium, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trevigen, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Essen Bioscience (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cayman Chemical Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abnova Corporation (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments